Cell Therapy Bioprocessing Market Analysis, Scope, and Growth by 2028
Cell Therapy Bioprocessing Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2020 | US$ 11.19 Billion |
Market Size by 2028 | US$ 30.05 Billion |
Global CAGR (2020 - 2028) | 13.5% |
Historical Data | 2018-2019 |
Forecast period | 2021-2028 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
By Technology
- Bioreactor
- Lyophilization
- Electrospinning
- Controlflow Centrifugation
- Ultrasonic Lysis
- Genome Editing Technology
- Cell Immortalization Technology
- Viral Vector Technology
By Cell Type
- Stem Cell
- Immune Cell
- Human Embryonic Stem Cell
- Pluripotent Stem Cell
- Hematopoetic Stem Cell
By Indication
- Cardiovascular Disease (CVD)
- Oncology
- Wound Healing
- Orthopedic
- Others
By End User
- Hospitals and Clinics
- Diagnostic Centers
- Regenerative Medicine Centers
- Academic and Research Institute
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Fresenius Kabi AG
- Asahi Kasei Corporation
- Sartorius AG
- MERCK KGaA
- THERMO FISHER SCIENTIFIC INC.
- Corning Incorporated
- Cytiva
- Lonza
- Repligen
- Catalent Inc